Results 201 to 210 of about 55,137 (249)

Percutaneous transluminal coronary angioplasty—I

The American Journal of Cardiology, 1979
Abstract To the editor: In their well-written editorial note in the February issue, Engel and Meister (1) raise appropriate caveats about the mixed blessings and potential dangers of the promising ...
openaire   +2 more sources

Percutaneous transluminal coronary angioplasty.

The Tokai journal of experimental and clinical medicine, 1987
Percutaneous transluminal coronary angioplasty (PTCA) is a nonoperative mechanical dilatation of atherosclerotic coronary artery stenosis by a balloon-tipped dilating catheter system. This method can effectively reduce highly stenotic coronary lesions and provide early recovery of ischemic but viable myocardium.
P. Leimgruber, A. R. Grüntzig
openaire   +3 more sources

Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.

New England Journal of Medicine, 1979
A. Grüntzig, Å. Senning, W. Siegenthaler   +2 more
semanticscholar   +1 more source

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

American Journal of Cardiology, 1984
D. Holmes, R. Vlietstra, Hugh C. Smith, G. Vetrovec, K. Kent, M. Cowley, D. Faxon, A. Gruentzig, S. Kelsey, K. Detre, M. Raden, M. Mock   +11 more
semanticscholar   +1 more source

Morbidity and mortality rates in elderly patients undergoing percutaneous coronary transluminal angioplasty.

American Heart Journal, 1994
J. Lindsay, V. Reddy, E. Pinnow, T. Little, A. Pichard   +4 more
semanticscholar   +1 more source

[Percutaneous transluminal coronary angioplasty].

Therapeutische Umschau. Revue therapeutique, 1991
Since its first application in a patient, PTCA has undergone a tremendous evolution: Based on growing experience and due to technical developments, indications have been markedly extended. Despite the fact that PTCA has been used in more risky situations, the primary success rate has risen and the rate of severe complications has dropped.
M, Pfisterer, W, Kiowski, H E, Schmitt, F, Burkart   +3 more
openaire   +1 more source

Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry.

New England Journal of Medicine, 1988
K. Detre, R. Holubkov, S. Kelsey, M. Cowley, K. Kent, David O. Williams, R. Myler, D. Faxon, D. Holmes, M. Bourassa, P. Block, A. Gosselin, L. Bentivoglio, L. Leatherman, G. Dorros, S. King, J. Galichia, M. Al-Bassam, Martin Leon, T. Robertson, E. Passamani   +20 more
semanticscholar   +1 more source

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

New England Journal of Medicine, 1988
L. Schwartz, M. Bourassa, J. Lésperance, H. Aldridge, F. Kazim, V. Salvatori, M. Henderson, R. Bonan, P. David   +8 more
semanticscholar   +1 more source

Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute.

American Journal of Cardiology, 1982
K. Kent, L. Bentivoglio, P. Block, M. Cowley, G. Dorros, A. Gosselin, A. Gruntzig, R. Myler, John T. Simpson, S. Stertzer, David O. Williams, L. Fisher, M. J. Gillespie, K. Detre, S. Kelsey, S. Mullin, M. Mock   +16 more
semanticscholar   +1 more source

Creatine kinase release after successful percutaneous transluminal coronary angioplasty.

American Heart Journal, 1985
J. Oh, C. Shub, D. Ilstrup, G. Reeder
semanticscholar   +1 more source